Physician profile
Nick Azar
NPI 1245544709
$2,822.07
in general payments reported to CMS, 2019-2025
10 companies · $468 in 2025
The $468 reported for 2025 was more than what 79% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5.38 · 2020: $670 · 2021: $188 · 2022: $110 · 2023: $530 · 2024: $851 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251 · Gift: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.43 |
| Gift | $597.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $1,098.22 | 2020-2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
| Align Technology, INC. | $743.89 | 2020-2025 | Invisalign, Invisalign First - Comprehensive |
| Ultradent Products INC | $597.43 | 2024 | Opalescence |
| Forestadent USA, INC. | $151.21 | 2019-2025 | |
| Ormco Corporation | $59.65 | 2022-2023 | Damon, Spark |
| Lightforce Orthodontics, INC. | $49.57 | 2022-2024 | |
| Hu-Friedy Mfg. Co., LLC | $40.00 | 2020 | |
| Nobel Biocare USA | $37.94 | 2023 | Nobelactive |
| Envista Holdings Corporation | $26.91 | 2024 | Spark |
| Solventum Corporation | $17.25 | 2025 | Transbond Plus, Apc Flash-Free Clarity Advanced, Transbond Mip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nick Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.